A message to shareholders from Joe Papa
I continue to view Bausch Health as the turnaround opportunity of a lifetime. The Company made considerable progress in 2018, and we are still gaining momentum, which we believe will carry over into 2019 and beyond.
Welcome to Bausch Health.
The decision to change our name was considered carefully over a long period of time. We looked at a number of available options and determined that Bausch Health most accurately represents the full scope of our portfolio, which includes not only pharmaceuticals, but also medical devices and over-the-counter consumer health products.